» Articles » PMID: 16085910

Naturally Acquired Antibodies Against Four Enterococcus Faecalis Capsular Polysaccharides in Healthy Human Sera

Overview
Date 2005 Aug 9
PMID 16085910
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Healthy human sera (HHS) contain naturally acquired enterococcal antibodies which promote neutrophil-mediated killing. The target antigens remain unknown. The present study used a capsular polysaccharide (CPS)-enzyme-linked immunosorbent assay (ELISA) to investigate whether the HHS antibodies of 12 healthy donors bound to the CPS of four E. faecalis serotypes (CPS-A to CPS-D) and then employed an opsonic-killing assay to determine if these antibodies mediated phagocyte-dependent killing. All HHS contained immunoglobulin G (IgG) and IgM antibodies directed against capsular polysaccharides of the four serotypes. Absorption of the sera with homologous and heterologous strains showed a majority of antibodies to be cross-reactive among the prototype strains. The susceptibility of the four prototype strains to opsonic killing varied. Opsonic killing of CPS-A and CPS-B strains was significantly higher than killing of CPS-C and CPS-D strains. Absorption studies revealed that the opsonic killing of HHS was only partially type specific, with cross-reactivity between CPS-A and CPS-B strains and between CPS-C and CPS-D strains. These data indicate that healthy individuals possess opsonic antibodies specific for CPS-A and CPS-B but only low titers of opsonic antibodies against CPS-C and CPS-D. Titers of opsonic antibodies did not correlate with antibody titers measured by ELISA. Whether this lack of correlation is due to the low frequency of opsonic antibodies or to increased resistance to the opsonophagocytic killing of some serotypes remains to be determined.

Citing Articles

: an overlooked cell invader.

Archambaud C, Nunez N, da Silva R, Kline K, Serror P Microbiol Mol Biol Rev. 2024; 88(3):e0006924.

PMID: 39239986 PMC: 11426025. DOI: 10.1128/mmbr.00069-24.


Elevation of enterococcus-specific antibodies associated with bacterial translocation is predictive of survival rate in chronic liver disease.

Iwasa M, Eguchi A, Tamai Y, Shigefuku R, Nakagawa R, Hasegawa H Front Med (Lausanne). 2022; 9:982128.

PMID: 36035413 PMC: 9403143. DOI: 10.3389/fmed.2022.982128.


Inhibition of the Classical Pathway of Complement Activation Impairs Bacterial Clearance during Enterococcus faecalis Infection.

Rabie Shehab El-Din E, Elgaml A, Ali Y, Hassan R Infect Immun. 2021; 89(5).

PMID: 33593889 PMC: 8091092. DOI: 10.1128/IAI.00660-20.


Exploration of the role of the virulence factor ElrA during Enterococcus faecalis cell infection.

Nunez N, Derre-Bobillot A, Gaubert S, Herry J, Deschamps J, Wei Y Sci Rep. 2018; 8(1):1749.

PMID: 29379180 PMC: 5788860. DOI: 10.1038/s41598-018-20206-6.


Synthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteria.

Laverde D, Wobser D, Romero-Saavedra F, Hogendorf W, van der Marel G, Berthold M PLoS One. 2014; 9(10):e110953.

PMID: 25333799 PMC: 4205086. DOI: 10.1371/journal.pone.0110953.


References
1.
Arduino R, Murray B, Rakita R . Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis. Infect Immun. 1994; 62(12):5587-94. PMC: 303306. DOI: 10.1128/iai.62.12.5587-5594.1994. View

2.
Wang Y, Huebner J, Tzianabos A, Martirosian G, Kasper D, Pier G . Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Carbohydr Res. 1999; 316(1-4):155-60. DOI: 10.1016/s0008-6215(99)00046-4. View

3.
Xu Y, Singh K, Qin X, Murray B, Weinstock G . Analysis of a gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis. Infect Immun. 2000; 68(2):815-23. PMC: 97210. DOI: 10.1128/IAI.68.2.815-823.2000. View

4.
Murray B . Vancomycin-resistant enterococcal infections. N Engl J Med. 2000; 342(10):710-21. DOI: 10.1056/NEJM200003093421007. View

5.
Musher D, Phan H, WATSON D, Baughn R . Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia. J Infect Dis. 2000; 182(1):158-67. DOI: 10.1086/315697. View